{"id":"W4224225208","doi":"10.51731/cjht.2022.313","title":"Rituximab for the Treatment of Primary Membranous Nephropathy","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nova Scotia Health Authority; Alberta Kidney Disease Network; Dalhousie University; University Health Network; University of Toronto; University of Calgary; Queen's University","funders":"Omeros Corporation","keywords":"Rituximab; Membranous nephropathy; Medicine; Cyclophosphamide; Tacrolimus; Internal medicine; Calcineurin; Nephrotic syndrome; Randomized controlled trial; Glomerulonephritis; Transplantation; Chemotherapy; Kidney; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001856726,0.0003215245,0.00121683,0.001292441,0.0002033868,0.000705255,0.000554501,0.0009354955,0.003957408],"category_scores_gemma":[0.003497785,0.0001391845,0.00228927,0.0007756337,0.0002975199,0.0005152699,0.0004172507,0.001129371,0.0004559439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009932437,"about_ca_system_score_gemma":0.001419012,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001867414,"about_ca_topic_score_gemma":0.003997316,"domain_scores_codex":[0.9984504,0.0008322962,0.0002490036,0.0001220104,0.0002730784,0.00007321501],"domain_scores_gemma":[0.9984745,0.0008755913,0.0003924036,0.00002564147,0.0001808897,0.00005083432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003257851,0.0001748506,0.001821709,0.1750413,0.007001464,0.0005889411,0.0001830459,0.0005226888,0.002430527,0.003256653,0.0454423,0.7602787],"study_design_scores_gemma":[0.007963912,0.004160949,0.01793925,0.1862761,0.032218,0.00779754,0.000351524,0.001056921,0.005065311,0.008014373,0.7290311,0.0001249392],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001109812,0.9970478,0.00009987473,0.0005617664,0.0001489697,0.00002427947,0.0000474966,0.000006443231,0.0009535223],"genre_scores_gemma":[0.05282371,0.9417731,0.0007724268,0.002792914,0.0005563775,0.0001004577,0.0002039797,0.000006111904,0.0009709051],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003957408,"threshold_uncertainty_score":0.01323891,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02853053291425916,"score_gpt":0.2749723424120416,"score_spread":0.2464418094977824,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}